International Rare Cancers Initiative (IRCI)

Affiliations

¹ Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD, UK.
² NCRN, University of Leeds, Leeds, UK.
³ Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, MD, USA.
⁴ Center for Global Health, NCI, Bethesda, MD, USA.
⁵ European Organisation for Research and Treatment of Cancer, Brussels, Belgium (DL, AN).

Nicola Keat et al. Ecancermedicalscience. 2013.

. 2013 May 21:7:ed20.

doi: 10.3332/ecancer.2013.ed20. eCollection 2013.

¹ Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD, UK.
² NCRN, University of Leeds, Leeds, UK.
³ Cancer Therapy Evaluation Program, Division of Cancer Treatment and Diagnosis, NCI, Bethesda, MD, USA.
⁴ Center for Global Health, NCI, Bethesda, MD, USA.
⁵ European Organisation for Research and Treatment of Cancer, Brussels, Belgium (DL, AN).

No abstract available

References

1. European parliament and council of the European communities. 1999. Decision no. 1295/1999/EC of the European parliament and of the council of 29 April 1999 adopting a programme of community action on rare diseases within the framework for action in the field of public health (1999–2003)
1. Available from http://www.fda.gov/orphan/oda.htm.
1. Gatta G, et al. Rare Cancers are not so Rare: The Rare Cancer Burden in Europe. Eur J Cancer. 2011;47(17):2493–511. - PubMed